7.5 semaglutide Wegovy (semaglutide) Injector 1.7 mg/0.75 mL, 4 Pens Per Box **Refrige — Mountainside Medical Information For Pharmacists | RYBELSUS®
Description
Avoid Rybelsus if there is a history, personal or family, of Medullary Thyroid Cancer or Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2)
Survodutide adds glucagon receptor agonism to GLP-1 signaling, aiming to improve on GLP-1 monotherapy by increasing energy expenditure and directly targeting hepatic fat
Cole GW, Headley J, Skowsky R
Find out more by calling or completing our online contact form
This is metabolically counterproductive because lean mass drives basal metabolic rate, and losing it makes weight regain more likely
